The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The approval was granted by Agenzia Italiana del Farmaco
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
Subscribe To Our Newsletter & Stay Updated
